NASDAQ : AZTA
Azenta, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 41.27 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.81B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.71B |
| Enterprise Value | 1.24B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 43.81M |
| Shares Outstanding | 43.81M |
| Shares Change (YoY) | -1.07% |
| Shares Change (QoQ) | -1.69% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 105.84% |
| Float | 38.88M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 82.81 |
| PS Ratio | 2.79 |
| Forward PS | 2.70 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.95 |
| P/FCF Ratio | 173.18 |
| P/OCF Ratio | 45.06 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.03 |
| EV / EBITDA | 37.67 |
| EV / EBIT | n/a |
| EV / FCF | 125.82 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.50 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 5.46 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -7.04% |
| Return on Assets (ROA) | -0.73% |
| Return on Invested Capital (ROIC) | -1.84% |
| Return on Capital Employed (ROCE) | -1.42% |
| Weighted Average Cost of Capital (WACC) | 12.24% |
| Revenue Per Employee | $211,658 |
| Profits Per Employee | -$42,378 |
| Employee Count | 2,900 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 4.30 |
Taxes
| Measure | Value |
|---|
| Income Tax | -40.17M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +31.12% |
| 50-Day Moving Average | 34.97 |
| 200-Day Moving Average | 28.37 |
| Relative Strength Index (RSI) | 57.44 |
| Average Volume (20 Days) | 1,086,709 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.36M |
| Short Previous Month | 5.32M |
| Short % of Shares Out | 12.24% |
| Short % of Float | 13.79% |
| Short Ratio (days to cover) | 4.44 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 613.81M |
| Gross Profit | 270.37M |
| Operating Income | -22.74M |
| Pretax Income | -152.26M |
| Net Income | -122.90M |
| EBITDA | 33.01M |
| EBIT | -22.74M |
| Loss Per Share | -$2.70 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 325.80M |
| Total Debt | 53.97M |
| Net Cash | 467.92M |
| Net Cash Per Share | $10.68 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 34.51 |
| Working Capital | 408.78M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 37.98M |
| Capital Expenditures | -28.09M |
| Depreciation & Amortization | 55.74M |
| Net Borrowing | -983,000 |
| Free Cash Flow | 9.88M |
| FCF Per Share | $0.23 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.05% |
| Operating Margin | -3.70% |
| Pretax Margin | -24.81% |
| Profit Margin | -20.02% |
| EBITDA Margin | 5.38% |
| EBIT Margin | -3.70% |
| FCF Margin | 1.61% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.07% |
| Shareholder Yield | 1.07% |
| Earnings Yield | -6.90% |
| FCF Yield | 0.58% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $37.80 |
| Price Target Difference | -3.23% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 4.46% |
| EPS Growth Forecast (3Y) | 10.47% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |